Cambrex to Invest More than $50 Million into Iowa Site Expansion

News
Article

The expansion will be designed to meet the growing demand for small molecule drug substance development and manufacturing.

Cambrex announced on Nov. 17, 2020 that it is investing more than $50 million into the expansion of its mid-scale and large-scale API manufacturing capacity in Charles City, IA.

Set to be operational by early 2022, the expansion will add three large-scale manufacturing work centers and a mid-scale work center to the facility, increasing its capacity by 30%, and giving Cambrex the opportunity to employ more than 400 people at the site, a company press release said. The expansion will be designed to meet the growing demand for small molecule drug substance development and manufacturing.

“Small molecule manufacturing demand has been growing consistently over recent years, and this investment will enable Cambrex to continue to capitalize on this growth, further strengthening our position as a market-leading CDMO,” said Joe Nettleton, president of Cambrex’s Drug Substance Business Unit, in the press release. “This expansion in the US for API manufacturing capacity comes at a time when our customers increasingly require high-quality partners to ensure reliable supply chains within the pharmaceutical sector.”

Source: Cambrex

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content